Lundbeck's CEO: Departing CFO is not defecting to competitor
Deborah Dunsire, CEO at Lundbeck, has yet to make plans for the nearest future after Chief Financial Officer Anders Götzsche has announced his departure from firm. He will remain at his post, however, until a successor has been appointed, and the company might look internally to find candidates, the CEO says.
by andreas lønstrup, translated by daniel pedersen
After 14 years at Lundbeck, Chief Financial Officer Anders Götzsche will depart the Danish pharmaceutical firm no later than May 2022. He is set to join another, as of yet undisclosed, unlisted Danish company.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Lundbeck's chief financial officer to exit before May 2022
For subscribers
Lundbeck appoints new chief commercial officer
For subscribers
Lundbeck Head of R&D denies allergy aspirations
For subscribers
